Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.50 |
| ▸ | CA2 | P00918 | 2/20 | 0.48 |
| ▸ | CA4 | P22748 | 2/20 | 0.48 |
| ▸ | CA12 | O43570 | 1/20 | 0.48 |
| ▸ | CA1 | P00915 | 1/20 | 0.48 |
| ▸ | CA7 | P43166 | 1/20 | 0.48 |
| ▸ | CA9 | Q16790 | 1/20 | 0.48 |
| ▸ | CA14 | Q9ULX7 | 1/20 | 0.48 |
| ▸ | MEN1 | O00255 | 1/20 | 0.47 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.47 |
| ▸ | LMNA | P02545 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 2/20 | 0.45 |
| ▸ | HPGD | P15428 | 2/20 | 0.45 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.45 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.45 |
| ▸ | TUBB1 | Q9H4B7 | 3/20 | 0.44 |
| ▸ | TUBB4A | P04350 | 1/20 | 0.44 |
| ▸ | TUBB | P07437 | 1/20 | 0.44 |
| ▸ | TUBA3C | P0DPH7 | 1/20 | 0.44 |
| ▸ | TUBA1B | P68363 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29732515 | 1.00 | SMN1; SMN2 (0.50) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL10842653 | 0.86 | SMN1; SMN2 (0.47) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL364729 | 0.85 | ALDH1A1 (0.46) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL24186496 | 0.85 | SMN1; SMN2 (0.45) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL24186589 | 0.85 | MEN1 (0.38) | SMN1; SMN2CA2CA4CA12CA1 | |
| Bromomethane SCHEMBL27848237 | 0.82 | SMN1; SMN2 (0.56) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL25434306 | 0.82 | CA1 (0.61) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL27753904 | 0.82 | CA1 (0.61) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL151213 | 0.82 | CA1 (0.61) | SMN1; SMN2CA2CA4CA12CA1 | |
| SCHEMBL16067896 | 0.81 | NCOA1 (0.47) | SMN1; SMN2MEN1KMT2ALMNAMAPT |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 150 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20070166609-A1 | ADDITIVES FOR NON-AQUEOUS ELECTROLYTE AND LITHIUM SECONDARY BATTERY USING THE SAME | LG CHEM, LTD. (KR) | 2007-07-19 | — | — | US | claimed |
| EP-4131456-B1 | ORGANIC LIGHT-EMITTING DEVICE | SFC CO LTD (KR) | 2026-02-18 | — | — | EP | disclosed |
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2025-09-25 | — | — | US | disclosed |
| US-20250048925-A1 | NOVEL ORGANIC LIGHT EMITTING DEVICE COMPRISING TWO LIGHT EMITTING LAYERS | SFC CO., LTD. (KR) | 2025-02-06 | — | — | US | disclosed |
| WO-2025021193-A1 | STEROID COMPOUND, AND PREPARATION METHOD THEREFOR AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| WO-2025020191-A1 | STEROID COMPOUND, PREPARATION METHOD THEREFOR, AND USE THEREOF | 珂阑(上海)医药科技有限公司 | 2025-01-30 | — | — | WO | disclosed |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | PEPTIDREAM INC (JP) | 2024-12-05 | — | — | US | disclosed |
| EP-4456703-A1 | NOVEL ORGANIC LIGHT EMITTING DEVICE COMPRISING TWO LIGHT EMITTING LAYERS | SFC Co., Ltd. (KR) | 2024-10-30 | — | — | EP | disclosed |
| US-12114660-B2 | Picolinamide compounds with fungicidal activity | CORTEVA AGRISCIENCE LLC (US) | 2024-10-15 | — | — | US | disclosed |
| CN-118414908-A | Novel organic light emitting element comprising two light emitting layers | SFC株式会社 | 2024-07-30 | — | — | CN | disclosed |
| US-4990657-A | From an aromatic halide without a phase transfer agent | RHONE-POULENC CHIMIE (FR) | 1991-02-05 | — | — | US | disclosed |
| EP-0255794-B1 | PROCESS FOR PREPARING AN AROMATIC ACID | RHONE-POULENC CHIMIE (FR) | 1990-11-07 | — | — | EP | disclosed |
| US-4918173-A | ANTITUMOR AGENTS; CHEMICAL INTERMEDIATES | LABORATORIES HOECHST S.A. (FR) | 1990-04-17 | — | — | US | disclosed |
| EP-0255794-A1 | Process for preparing an aromatic acid | RHONE-POULENC CHIMIE (FR) | 1988-02-10 | — | — | EP | disclosed |
| EP-0207424-A2 | Anthracyclins | LABORATOIRES HOECHST S.A. (FR) | 1987-01-07 | — | — | EP | disclosed |
| US-4495353-A | ETHERIFICATION OF A HALOAROMTIC COMPOUND | STERLING DRUG INC. (US) | 1985-01-22 | — | — | US | disclosed |
| EP-0057321-B1 | PROCESSES FOR SUBSTITUTION OF AROMATIC ORGANIC COMPOUNDS | STERWIN AG. (CH) | 1984-03-21 | — | — | EP | disclosed |
| US-4422955-A | REPLACING HALOGEN ATOM ATTACHED TO RING WITH ALKOXY-TYPE SUBSTITUENT USING AS CATALYST A FORMIC ACID ESTER AND A CUPROUS SALT | STERLING DRUG INC. (US) | 1983-12-27 | — | — | US | disclosed |
| US-4415577-A | ANTIARRHYTHMIA AGENTS | KALI-CHEMIE PHARMA GMBH (DE) | 1983-11-15 | — | — | US | disclosed |
| EP-0057321-A1 | Processes for substitution of aromatic organic compounds | STERWIN AG. (CH) | 1982-08-11 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250296915-A1 | NOVEL AMINO ACID DERIVATIVES | DNPEP, BCAT1, ANPEP | SMN1; SMN2 3657/4885CA2 4029/4885CA4 4053/4885 |
| US-12114660-B2 | Picolinamide compounds with fungicidal activity | PFAS, CASP2, CYP1A2 | SMN1; SMN2 2463/4885CA2 247/4885CA4 1687/4885 |
| US-20240400499-A1 | NOVEL AMINO ACID DERIVATIVES | BCAT1, BCAT2, PELP1 | SMN1; SMN2 4155/4885CA2 3956/4885CA4 4347/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.